AzTrials
AzTrials

Adult Spinal DeformityNCT02949245

Neurologic Complications in Spinal Deformity Surgery - Extension

An observational study of Adult Spinal Deformity, run by AO Foundation, AO Spine at 11 sites in 6 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

272 subjects with "high risk" adult spinal deformity requiring surgical correction were enrolled in the previous prospective multi-center international Scoli-RISK-1 study. "High risk" patients were defined by either their diagnoses and/or the type of surgical intervention as listed in the inclusion criteria. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Adult Spinal Deformity
What is being tested?
Interventions
Type of treatment
Surgery or procedure
How many people
77 participants
Where
11 sitesin 6 countries
Study dates
17 Aug 2017to 28 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participant completed Scoli-RISK-1 study are potential subjects for this observational study.

Who may be able to join

  • Participant completed Scoli-RISK-1 study (no withdraws or drop-outs)
  • Signed informed consent for extended study

Who cannot join

  • Subjects enrolled in Scoli-RISK-1 which are unlikely to comply with the FU
  • Subjects which by law are not eligible to participate any longer in clinical trials

Trial locations and contacts

11 sites in 6 countries.

11 sites in 6 countries

United States5 sites
  • Johns Hopkins University

    Baltimore, Maryland, 21205

  • University of Virginia

    Charlottesville, Virginia, 22903

  • NYU School of Medicine

    New York, New York, 10023

  • University of California

    San Francisco, California, 94118

  • Department of Orthopaedic Surgery, Washington University School of Medicine

    St Louis, Missouri, 63110

Other trials in United States

China2 sites
  • University of Hong Kong

    Hong Kong, 102

  • Nanjing Drum Tower Hospital

    Nanjing, 210008

Other trials in China

Canada1 site
  • University of Toronto Hospital

    Toronto, Ontario, M5T 2S8

Other trials in Canada

Japan1 site
  • Hamamatsu University School of Medicine

    Hamamatsu, 3192

Other trials in Japan

Spain1 site
  • Hospital Universitari Vall D'Hebron

    Barcelona, 08035

Other trials in Spain

United Kingdom1 site
  • University Hospital Nottingham, NHS Trust

    Nottingham, NG7 2UH

Other trials in United Kingdom

About this study

Official title: Evaluation of Neurologic Complications Associated With Surgical Correction of Adult Spinal Deformity (Scoli-RISK-1): A Prospective, Observational, Multi-center Study 5 Year Follow-up Extension

272 subjects with "high risk" adult spinal deformity requiring surgical correction were enrolled in the previous prospective multi-center international Scoli-RISK-1 study. "High risk" patients were defined by either their diagnoses and/or the type of surgical intervention as listed in the inclusion criteria. Neurological complications in the form of new motor and sensory deficits were monitored prospectively in all patients at hospital discharge, at 6 weeks (± 2 weeks), 6 months (± 2 months) and 24 months (± 2 months) after the surgery. The relationship to the surgical intervention was assessed in all new deficits.

Regression analyses were used to evaluate the association between patient demographics, co-morbidities, treatment history, spinal deformity characteristics, surgical characteristics, non-neurologic complications and pre-surgical status to occurrence of a neurologic deficit after surgery.

All enrolled Scoli-RISK-1 participants will be re-consented and asked to return for a 5 year FU visit.

Read the detailed description

Although the incidence of complications in patients undergoing correction of their spinal deformity has been reported extensively, the majority of these studies were retrospective. There were only five studies, three from a single institution, with prospectively collected data that specifically identified complications. The largest series was from Buchowski et al who reported on 108 patients with fixed sagittal deformity undergoing Pedicle Subtraction Osteotomy (PSO) with a 14% over-all complication rate with motor weakness in 11 patients and neurogenic bladder in one patient, of which 3 were permanent. Yang reported on 35 patients undergoing PSOs with a 46% over-all complication rate and one transient nerve root motor deficit. As in 2002 reported on 83 patients undergoing various osteotomies for sagittal imbalance and reported a 34% over-all complication rate with 3 permanent and 3 transient nerve root deficits.

Given this lack of information, there is a need to determine the true incidence of complications using a prospective multi-center design. There is a need to identify neurologic deficits in a more systematic fashion to include spinal cord, cauda equina and nerve root deficits as well as radiculopathies. The risk factors associated with the occurrence of a complication, especially a neurologic complication, also needs to be more fully elucidated. This is increasingly relevant, as newer surgical techniques allow for more aggressive correction of the spinal deformity that may put the spinal cord and nerve roots at increased risk. Valid data on the incidence and types of neurologic deficits is also needed in order to study newer drugs that are available that may mitigate this risk.

The primary objectives of this study are: (i) to establish the incidence of neurologic deficit in "high risk" adult patients undergoing correction of their spinal deformity of adult spinal deformity and (ii) to identify characteristics associated with increased risk of neurologic complications. Secondary objectives include (i) to determine the incidence of all complications related to surgical correction of "high risk" adult spinal deformity; (ii) to determine the short-term clinical outcomes in patients undergoing correction of their spinal deformity and (iii).to determine amount of radiographic and clinical correction of deformity

Being tested
Interventions
Keywords
Spine, Surgery, Prospective Studies, Deformity, Neurologic deficit
Medical subject headings
Congenital Abnormalities, Neurologic Manifestations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterventionsProcedure or surgery

    Procedure/Surgery: Routinely performed surgical correction of spinal deformity

    Routinely performed surgical correction of spinal deformity

Study groups in NCT02949245
Study groupRoleWhat they receive
Groups/CohortsSurgical treatment This observational study is examining the outcomes of standard surgical treatments for adult spinal deformity.
Receives: Procedure: Interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of neurologic complication

    Rate of treatment-related neurological complications determined by the Clinical Endpoint Committee (CEC) whether complications are of neurological nature or not.

    Measured: 5 years postoperative

  2. Absolute change in motor status as measured by the ASIA LEMS

    Measured: between baseline and 5 years postoperative

Secondary outcomes (6)
  1. ASIA Sensory Score

    Sensory status as measured by the ASIA Sensory Score

    Measured: Change between baseline and 5 years postoperative

  2. ASIA Impairment Scale

    Neurological status as measured by the ASIA Impairment Scale

    Measured: Change between baseline and 5 years postoperative

  3. SRS-22R

    Function, pain and self-image as measured by the SRS-22R

    Measured: Change between baseline and 5 years postoperative

  4. ODI v2.1a

    Functional impairment as measured by the ODI v2.1a score

    Measured: Change between baseline and 5 years postoperative

  5. SF-36 v2.0

    Quality of life as measured by the SF-36 v2.0

    Measured: Change between baseline and 5 years postoperative

  6. Radiographic measures

    major coronal curve, coronal balance, sagital alignment, T2-T12 sagital cobb, T12-S1 sagital cobb, major sagital curve

    Measured: Change between baseline and 5 years postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2016 (estimated)
  2. Study start17 Aug 2017
  3. Primary completion28 Dec 2019
  4. Study completion28 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
77 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02949245
Sponsor's protocol ID
Scoli-RISK-1 extension
Status last verified
May 2020
First submitted
24 Oct 2016
Last updated
19 May 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Adult Spinal Deformity, run by AO Foundation, AO Spine at 11 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in United States, China, Canada, Japan, Spain and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of neurologic complication (time frame: 5 years postoperative). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2020; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in